Echo IQ announced that it will be collaborating with Beth Israel Deaconess Medical Center (BIDMC), the world-class teaching hospital of Harvard Medical School, on a clinical study of the Company's technology. The study, a retrospective clinical cohort and outcomes study, is being conducted to evaluate Echo IQ's artificial intelligence algorithm in detecting individuals with severe aortic stenosis and equivalent risk of mortality associated with an aortic stenosis phenotype in a North American cohort. The Principal Investigator of the study is Jordan B. Strom, MD, MSc, FACC, FASE, Assistant Professor of Medicine at Harvard Medical School, Director of Echocardiographic Research, and Associate Director of the Echocardiography Laboratory at Beth Israel Deaconess Medical Center.

He is a faculty investigator and Section Head for Cardiovascular Imaging Research at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology. This study adds to those already in progress by the Company and is expected to augment an already- extensive body of research in this important space. Aortic stenosis is the most prevalent form of heart valve disease in high-income countries and recent estimates from the UK and Australia indicate that its prevalence will increase in line with the progressive ageing of the population.

Echo IQ is using the power of AI to support enhanced diagnosis of this condition, and other forms of structural heart disease.